Intertrust Expands ExpressPlay Platform to Provide Seamless DRM Interoperability, Conditional Access, Audience Analytics, and Targeted Advertising
Intertrust Technologies Corporation today announced a major expansion of Intertrust ExpressPlay™, its cloud platform that provides content distributors, network operators, and broadcasters with a single service that satisfies all their media monetization requirements in a highly cost-effective and efficient way. The platform is the first of its kind to combine content protection and management with audience understanding and targeted advertising to offer greater convenience, security, privacy and risk management in a single solution.
Traditionally, companies distributing Internet video procured these services from two or more vendors, creating risk, additional cost, and confusion. ExpressPlay provides convenience at a significantly lower price, and is built on years of R&D embodied in Intertrust’s seminal patent portfolio.
Intertrust expands its traditional ExpressPlay DRM platform, which to date is the only cloud-based platform that supports all major DRM formats. In a major leap forward in DRM systems, ExpressPlay introduces a new Universal DRM SDK that promises to end cross-device DRM format conflicts decisively. Service providers building applications with the ExpressPlay Universal SDK can use all major DRMs without custom integration for each one. The Universal DRM SDK also supports DASH CENC to native FairPlay, and offers the protected (DRM) DASH stack for iOS, which doesn’t exist natively. This means that service providers can reduce multiple asset formats, streamline their workflows and deliver premium content using the native DRM.
The new platform also uses the Intertrust Personagraph™ consumer data platform to provide server-side and client-side advertising, and audience understanding. A network operator or broadcaster can now use ExpressPlay to deploy and manage content in a common secure format, provide targeted ads using their own infrastructure and run analytics on their users’ data securely and privately without dependencies on competitors.
Intertrust ExpressPlay now includes,
- ExpressPlay Universal DRM™ (uDRM): Intertrust’s leading multi-DRM platform that supports Adobe Access, Apple FairPlay, Google Widevine, Marlin DRM, and Microsoft PlayReady. The new Universal DRM (uDRM) SDK helps reduce costs by eliminating the need to distribute multiple versions of protected assets. It overcomes the challenges of the diverse device landscape (flavors of Android, iOS, etc), and efficiently implements offline playback of content on mobile devices. uDRM minimizes the need for complex backend systems and professional services.
- ExpressPlay CA™: A new Marlin-based Conditional Access System (CAS) that allows broadcasters and network operators to deliver card-free, powerful CAS capabilities using the same Marlin DRM engine used for broadband DRM. One engine supports two security models and results in substantial savings over traditional limited CAS.
- ExpressPlay Audience™: An advanced customer data platform that leverages Intertrust’s multi-billion user Personagraph consumer data platform. Audience provides understanding, advanced analytics, device graphs, and retail and marketing technology functions in a private and secure manner.
- ExpressPlay Ads™: A custom white-label advertising platform that uses ExpressPlay Audience to insert personalized ads into protected content streams on mobile, TV, and web platforms. The platform supports both server-side and client-side ad insertion technology to reach a broad range of devices in a highly scalable and efficient manner.
This is the first platform of its kind that provides convenience, security, privacy, and risk management. The components can be used jointly as a complete system or separately.
Intertrust will showcase ExpressPlay and related partner demos at IBC 2017 at the RAI in Amsterdam in Hall 5, Booth 15 between September 15-19, 2017.
About Intertrust Technologies Corporation
Intertrust provides trusted computing products and services to leading global corporations – from mobile and CE manufacturers and service providers to enterprise software platform companies. These products include the world’s leading digital rights management, software tamper resistance and privacy-driven data platforms for digital advertising, marketing technologies, DNA analysis, and IoT.
Founded in 1990, Intertrust is based in Silicon Valley, with regional offices in London, Tokyo, Seoul and Beijing. The Company has a legacy of invention, and its fundamental contributions in the areas of computer security and digital trust are globally recognized. Intertrust holds hundreds of patents that are key to Internet security, trust, and privacy management components of operating systems, trusted mobile code and networked operating environments, web services, and cloud computing. Additional information is available at intertrust.com, or follow us on Twitter or LinkedIn.
Brian Regan (for Intertrust), 908-399-7161
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37 | Pressemelding
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f
Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference19.4.2018 15:45 | Pressemelding
Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced that Rodolphe Hajj, Ph.D., the Company’s Chief Pharmacology Officer, will present at the 8th Annual Global Orphan Drug Conference. The presentation will take place as follows: Date & Time: Wednesday April 25th at 4:40 pm EST Title: “Next generation drug repurposing using network pharmacology to develop new therapeutic entities for rare diseases” Venue: Gaylord National Harbor Hotel, Oxon Hill, MD, U.S. Pharnext’s team will also attend the 2018 American Academy of Neurology Annual Meeting as a first-time exhibitor (booth 908). The meeting will take place on April 21-27, 2018 in Los Angeles, CA, U.S. If you are interested in meeting the Pharnext management team during these events, please send an email to firstname.lastname@example.org. About Pharnext Pharne
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices19.4.2018 15:01 | Pressemelding
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management (PBM).1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419005949/en/ Masimo Radical-7® with SpHb® and RD rainbow SET™ Sensor (Photo: Business Wire) In the study, Prof. Baricchi and colleagues in the Transfusion Medicine Unit, AUSL-IRCCS of Reggio Emilia and at the Department of Medicine and Surgery at the University of Parma, Italy, sought to evaluate the appropriateness of post-operative RBC transfusion over a three-year period (2013-2015), before and after implementation of a patient blood managem
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform19.4.2018 14:06 | Pressemelding
Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies bringing new medicines to market, has enhanced its focus. The CRO today announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease. In addition, Synteract revealed its new market positioning with an updated logo, tagline, and website to reinforce its core capabilities. Synteract’s leadership has been proven in these core development areas, over its nearly 30-year history, through its contributions to more than 240 product approvals. Formal establishment of its new centers of development bring more visibility to Synteract’s longstanding, specialized expertise in these complex areas of clinical research. Synteract CEO Steve Powell says, “By aligning operational excel
Nel ASA: Receives Additional Purchase Order from Nikola19.4.2018 14:00 | Pressemelding
Nel ASA (Nel, OSE: NEL) has received a USD 5.5 million purchase order from Nikola Motor Company (Nikola), as part of the previously announced hydrogen stations. “We are very proud to announce that we have received an additional order from Nikola related to the electrolyzer and fueling solution for their prototype trucks. The order marks a strengthening of our partnership and is a recognition of the level of competence our team and hydrogen solutions can offer. We look forward to supplying the demo stations, which will lay the groundwork for the world’s largest, most efficient network of low-cost hydrogen production and fueling sites,” says Jon André Løkke, Chief Executive Officer of Nel. On November 15, 2017, Nikola and Nel announced the exclusive partnership and a purchase order for two so-called demo hydrogen refueling stations for Nikola's fleet of prototype hydrogen trucks. The partnership aims at developing low-cost, renewable hydrogen production and fueling sites for the potentia
Voith and Franka Emika Form a Strategic Partnership19.4.2018 13:39 | Pressemelding
The technology company Voith and the Munich-based robotics company Franka Emika have entered into a strategic partnership. Part of the strategic partnership is the establishment of a new joint venture called Voith Robotics – A Voith and Franka Emika Company. The company, with headquarters in Munich, is to become a global system supplier for robot-assisted automation in the digital age. Voith Robotics will offer self-teaching lightweight robots made by Franka Emika, along with software solutions, apps, services and process consulting, to customers in various industries and markets throughout the world. As part of the strategic partnership Voith will also have a direct stake in Franka Emika, thus emphasizing the long-term and strategic commitment by the two companies to cooperation. Martin Scherrer, formerly a member of the Board of Management of Voith Paper, will be the new chief executive officer of Voith Robotics, which is to be managed by Voith. The still very young market for collab